益生菌市场－全球产业规模、份额、趋势、机会和预测，按类型、畜种、功能、剂型、地区和竞争格局划分，2020-2030年预测

2024年全球益生菌市场规模为79.4亿美元，预计到2030年将以7.91%的复合年增长率成长至125.4亿美元。益生菌涵盖益生菌、益生元、有机酸和精油等成分，用于促进动物肠道菌丛平衡，进而提升动物的整体健康和生产力。市场成长的主要驱动因素包括：对天然饲料添加剂的需求不断增长、人们对畜牧业健康意识的提高以及全球对抗生素生长促进剂的监管限制。

主要市场驱动因素

全球益生菌市场的成长受到抗生素生长促进剂严格监管的显着影响。

主要市场挑战

阻碍全球益生菌市场成长的一大挑战是高昂的生产成本和复杂的监管架构。

主要市场趋势

益生菌製剂和递送技术的进展

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：客户之声

第五章：全球益生菌市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按类型（益生菌、益生元、有机酸、精油）
  • 依牲畜（家禽、猪、反刍动物、水生动物、其他）分类
  • 依功能分类（营养与肠道健康、产量、免疫力与生产）
  • 按形态（干粉、液体）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美益生菌市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲益生菌市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区益生菌市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲优生学市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲优生学市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球益生菌市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Novozymes A/S
• Cargill, Incorporated
• DuPont de Nemours, Inc.
• Koninklijke DSM NV
• Lallemand Inc.
• Novus International, Inc.
• Kemin Industries, Inc.
• Asahi Group Holdings, Ltd.

第十六章：策略建议

第17章调查会社について・免责事项

The Global Eubiotics Market, valued at USD 7.94 Billion in 2024, is projected to grow at a CAGR of 7.91% to reach USD 12.54 Billion by 2030. Eubiotics-encompassing probiotics, prebiotics, organic acids, and essential oils-are used to promote a balanced gut microflora in animals, enhancing overall health and productivity. Market growth is primarily driven by rising demand for natural feed additives, heightened awareness of livestock health, and global regulatory restrictions on antibiotic growth promoters.

Key Market Drivers

The growth of the Global Eubiotics Market is significantly influenced by stringent regulations on antibiotic growth promoters

Global regulatory efforts to combat antimicrobial resistance are compelling livestock producers to adopt alternatives to antibiotic growth promoters, thereby accelerating demand for eubiotics. According to the European Medicines Agency's thirteenth annual ESVAC report published in November 2023, sales of veterinary antibiotics in 25 European countries declined by 53% between 2011 and 2022, creating a substantial shift toward non-antibiotic feed additives. In parallel, rising consumer preference for antibiotic-free animal products strengthens market demand. Growing awareness of antibiotic residues in meat and the public health threat of antimicrobial resistance has led consumers to favor proteins produced through natural feed solutions. The European Environment Agency reported in May 2024 that antimicrobial-resistant infections cause approximately 35,000 deaths annually in the European Economic Area, reinforcing consumer urgency. This industry momentum is further reflected in related sectors, such as dsm-firmenich's Feed Enzymes Alliance, which accounted for about €300 million in annual net sales in 2024, demonstrating strong market activity in advanced feed solutions.

Key Market Challenges

A significant challenge impeding the growth of the Global Eubiotics Market is the combination of high production costs and complex regulatory frameworks

Advanced eubiotic formulations require substantial investment in production, resulting in higher product prices that can limit adoption, especially among small and medium-sized livestock operations. This cost barrier reduces competitiveness against traditional feed additives. Additionally, stringent regulatory standards significantly increase development expenses and time-to-market. Extensive safety and efficacy testing is required for approval, further elevating costs and slowing innovation. Eurostat reported that EU gross domestic expenditure on research and development reached €389 billion in 2023, illustrating the high financial burden associated with innovation in regulated sectors such as feed additives. These combined pressures limit new product entry and restrict the market's ability to scale rapidly.

Key Market Trends

Advancements in Eubiotic Formulation and Delivery Technologies

Innovations in formulation are enabling more stable, targeted, and effective eubiotic products designed to withstand gastrointestinal conditions and deliver optimal benefits. These advancements improve nutrient absorption, gut health, and overall animal performance. In 2023, Novozymes partnered with Bactolife to commercialize Ablacto+, a biosolution aimed at improving piglet gut stability and reducing post-weaning diarrhea, highlighting the movement toward next-generation biological products.

Key Market Players

• Novozymes A/S
• Cargill, Incorporated
• DuPont de Nemours, Inc.
• Koninklijke DSM N. V.
• Lallemand Inc.
• Novus International, Inc.
• Kemin Industries, Inc.
• Asahi Group Holdings, Ltd.

Report Scope:

In this report, the Global Eubiotics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Eubiotics Market, By Type:

• Probiotics
• Prebiotics
• Organic Acids
• Essential Oils

Eubiotics Market, By Livestock:

• Poultry
• Swine
• Ruminants
• Aquatic Animals
• Others

Eubiotics Market, By Function:

• Nutrition & Gut Health
• Yield
• Immunity & Production

Eubiotics Market, By Form:

• Dry
• Liquid

Eubiotics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Eubiotics Market.

Available Customizations:

Global Eubiotics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Eubiotics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Probiotics, Prebiotics, Organic Acids, Essential Oils)
  • 5.2.2. By Livestock (Poultry, Swine, Ruminants, Aquatic Animals, Others)
  • 5.2.3. By Function (Nutrition & Gut Health, Yield, Immunity & Production)
  • 5.2.4. By Form (Dry, Liquid)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Eubiotics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Livestock
  • 6.2.3. By Function
  • 6.2.4. By Form
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Eubiotics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Livestock
      • 6.3.1.2.3. By Function
      • 6.3.1.2.4. By Form
  • 6.3.2. Canada Eubiotics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Livestock
      • 6.3.2.2.3. By Function
      • 6.3.2.2.4. By Form
  • 6.3.3. Mexico Eubiotics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Livestock
      • 6.3.3.2.3. By Function
      • 6.3.3.2.4. By Form

7. Europe Eubiotics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Livestock
  • 7.2.3. By Function
  • 7.2.4. By Form
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Eubiotics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Livestock
      • 7.3.1.2.3. By Function
      • 7.3.1.2.4. By Form
  • 7.3.2. France Eubiotics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Livestock
      • 7.3.2.2.3. By Function
      • 7.3.2.2.4. By Form
  • 7.3.3. United Kingdom Eubiotics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Livestock
      • 7.3.3.2.3. By Function
      • 7.3.3.2.4. By Form
  • 7.3.4. Italy Eubiotics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Livestock
      • 7.3.4.2.3. By Function
      • 7.3.4.2.4. By Form
  • 7.3.5. Spain Eubiotics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Livestock
      • 7.3.5.2.3. By Function
      • 7.3.5.2.4. By Form

8. Asia Pacific Eubiotics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Livestock
  • 8.2.3. By Function
  • 8.2.4. By Form
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Eubiotics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Livestock
      • 8.3.1.2.3. By Function
      • 8.3.1.2.4. By Form
  • 8.3.2. India Eubiotics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Livestock
      • 8.3.2.2.3. By Function
      • 8.3.2.2.4. By Form
  • 8.3.3. Japan Eubiotics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Livestock
      • 8.3.3.2.3. By Function
      • 8.3.3.2.4. By Form
  • 8.3.4. South Korea Eubiotics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Livestock
      • 8.3.4.2.3. By Function
      • 8.3.4.2.4. By Form
  • 8.3.5. Australia Eubiotics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Livestock
      • 8.3.5.2.3. By Function
      • 8.3.5.2.4. By Form

9. Middle East & Africa Eubiotics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Livestock
  • 9.2.3. By Function
  • 9.2.4. By Form
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Eubiotics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Livestock
      • 9.3.1.2.3. By Function
      • 9.3.1.2.4. By Form
  • 9.3.2. UAE Eubiotics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Livestock
      • 9.3.2.2.3. By Function
      • 9.3.2.2.4. By Form
  • 9.3.3. South Africa Eubiotics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Livestock
      • 9.3.3.2.3. By Function
      • 9.3.3.2.4. By Form

10. South America Eubiotics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Livestock
  • 10.2.3. By Function
  • 10.2.4. By Form
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Eubiotics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Livestock
      • 10.3.1.2.3. By Function
      • 10.3.1.2.4. By Form
  • 10.3.2. Colombia Eubiotics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Livestock
      • 10.3.2.2.3. By Function
      • 10.3.2.2.4. By Form
  • 10.3.3. Argentina Eubiotics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Livestock
      • 10.3.3.2.3. By Function
      • 10.3.3.2.4. By Form

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Eubiotics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Novozymes A/S
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Cargill, Incorporated
• 15.3. DuPont de Nemours, Inc.
• 15.4. Koninklijke DSM N. V.
• 15.5. Lallemand Inc.
• 15.6. Novus International, Inc.
• 15.7. Kemin Industries, Inc.
• 15.8. Asahi Group Holdings, Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer